Skip to main content
. Author manuscript; available in PMC: 2014 May 14.
Published in final edited form as: JAMA Neurol. 2014 May 1;71(5):581–588. doi: 10.1001/jamaneurol.2014.94

Table 4.

Hazard Ratios for Association of Mild Cognitive Impairment by COPD Duration

Model 1a Model 2b Model 3c

COPD duration ≤ 5 years COPD duration > 5 years COPD duration ≤ 5 years COPD duration > 5 years COPD duration ≤ 5 years COPD duration > 5 years

MCI Type Incident MCI/At risk, N HR (95% CI) HR (95% CI) Incident MCI/At risk, N HR (95% CI) HR (95% CI) Incident MCI/At risk, N HR (95% CI) HR (95% CI)
Any MCI 370/1,425 1.22 (0.79, 1.88) 1.49 (1.04, 2.14) 356/1,375 1.26 (0.82, 1.95) 1.57 (1.09, 2.26) 318/1,250 1.11 (0.70, 1.74) 1.58 (1.04, 2.40)
Amnestic MCI 230/1,425 1.23 (0.72, 2.10) 0.58 (0.29, 1.15) 222/1,375 1.26 (0.74, 2.15) 0.56 (0.27, 1.15) 203/1,250 1.23 (0.71, 2.13) 0.67 (0.32, 1.42)
Non- Amnestic MCI 97/1,425 1.21 (0.51, 2.90) 2.63 (1.51, 4.58) 92/1,375 1.30 (0.54, 3.13) 2.97 (1.70, 5.18) 83/1,250 1.14 (0.46, 2.79) 2.58 (1.32, 5.06)

Abbreviations: COPD, chronic obstructive pulmonary disease; MCI, mild cognitive impairment.

No-COPD is the reference group [HR 1.00] for all the analyses. Numbers in bold denotes significant association.

a

Model 1 adjusted for education as a continuous variable, sex where applicable, and age at baseline as time variable.

b

Model 2 additionally adjusted for BDI-II Depression, and history of stroke.

c

Model 3 includes model 2 variables, with additional adjustment for APOEe4 genotype, smoking, diabetes, hypertension, coronary artery disease, z-scores and BMI.